FDA 483 - Viyash Life Sciences Private Limited - April 25, 2025

An FDA inspection of Viyash Life Sciences Private Limited, an API manufacturer in Taluka Panval, Maharashtra, India, revealed two significant observations. The firm failed to perform required testing for raw materials used in active pharmaceutical ingredients and also had an inadequate stability testing program, specifically lacking appearance/description testing for an API.